ES2128519T3 - Nuevas pirido-tiadiazinas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. - Google Patents

Nuevas pirido-tiadiazinas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.

Info

Publication number
ES2128519T3
ES2128519T3 ES94400627T ES94400627T ES2128519T3 ES 2128519 T3 ES2128519 T3 ES 2128519T3 ES 94400627 T ES94400627 T ES 94400627T ES 94400627 T ES94400627 T ES 94400627T ES 2128519 T3 ES2128519 T3 ES 2128519T3
Authority
ES
Spain
Prior art keywords
tiadiazinas
pirido
contain
new
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94400627T
Other languages
English (en)
Inventor
Bernard Pirotte
Tullio Pascal De
Bernard Masereel
Jacques Delarge
Jean Lepagnol
Pierre Renard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIR SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Application granted granted Critical
Publication of ES2128519T3 publication Critical patent/ES2128519T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Abstract

LA INVENCION SE REFIERE A LOS COMPUESTOS DE FORMULA (I): EN LA QUE A, R1, R2 Y R4 SON TALES COMO SE DEFINEN EN LA DESCRIPCION. MEDICAMENTOS.
ES94400627T 1993-03-26 1994-03-24 Nuevas pirido-tiadiazinas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. Expired - Lifetime ES2128519T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9303458A FR2703051B1 (fr) 1993-03-26 1993-03-26 Nouvelles pyridothiadiazines, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.

Publications (1)

Publication Number Publication Date
ES2128519T3 true ES2128519T3 (es) 1999-05-16

Family

ID=9445338

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94400627T Expired - Lifetime ES2128519T3 (es) 1993-03-26 1994-03-24 Nuevas pirido-tiadiazinas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.

Country Status (13)

Country Link
US (1) US5459138A (es)
EP (1) EP0618209B1 (es)
JP (1) JP2513989B2 (es)
AT (1) ATE174920T1 (es)
AU (1) AU673893B2 (es)
CA (1) CA2119853C (es)
DE (1) DE69415373T2 (es)
DK (1) DK0618209T3 (es)
ES (1) ES2128519T3 (es)
FR (1) FR2703051B1 (es)
GR (1) GR3029406T3 (es)
NZ (1) NZ260186A (es)
ZA (1) ZA942131B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5488056A (en) * 1994-10-31 1996-01-30 Eli Lilly And Company Method for treating anxiety
AU713847B2 (en) * 1995-11-15 1999-12-09 Yamanouchi Pharmaceutical Co., Ltd. Inhibitor of Kainic acid neurotoxicity and pyridothiazine derivative
IL125072A (en) * 1996-01-17 2002-12-01 Novo Nordisk As HISTORY OF PYRIDO - 4,2,1 thiodiazine-3 amine and pharmaceutical preparations containing them
US6225310B1 (en) 1996-01-17 2001-05-01 Novo Nordisk A/S Fused 1,2,4-thiadiazine derivatives, their preparation and use
KR19990077319A (ko) * 1996-01-17 1999-10-25 한센 핀 베네드, 안네 제헤르 축합된 1,2,4-티아디아진 및 축합된 1,4-티아진 유도체, 그것의제조방법 및 사용
CA2250856A1 (en) * 1996-04-19 1997-10-30 The Regents Of The University Of California Treatment of mood/affective disorders by glutamatergic upmodulators
DE69705821T2 (de) * 1996-09-24 2001-11-08 Dow Agrosciences Llc N-((1,2,4)triazoloazinyl)benzolsulfonamid- und pyridinsulfonamidverbindungen und deren verwendung als herbizide
US6329368B1 (en) * 1997-05-09 2001-12-11 The Regents Of The University Of California Endocrine modulation with positive modulators of AMPA type glutamate receptors
WO1999003861A1 (en) * 1997-07-16 1999-01-28 Novo Nordisk A/S Fused 1,2,4-thiadiazine derivatives, their preparation and use
WO1999032495A1 (en) * 1997-12-19 1999-07-01 Novo Nordisk A/S Pyrido 1,2,4-thiadiazine derivatives, their preparation and use
DE19824232A1 (de) * 1998-05-29 1999-12-02 Bayer Ag Pyridodithiazindioxide
DE19918021C1 (de) 1999-04-21 2000-06-29 Ruetgers Organics Gmbh Verfahren zur Herstellung von chlorierten Pyridinsulfonsäurechloriden
WO2001002410A1 (en) * 1999-06-30 2001-01-11 Novo Nordisk A/S Novel process
PL370039A1 (en) 2000-03-20 2005-05-16 Teva Pharmaceutical Industries Ltd. Novel processes for preparing torsemide intermediate
AU2001265841A1 (en) * 2000-06-26 2002-01-08 Novo-Nordisk A/S Use of potassium channel openers for the treatment of insulitis
AU2002307327A1 (en) * 2001-05-04 2002-11-18 Eli Lilly And Company Use of an ampa receptor potentiator for the manufacture of a medicament for the treatment of type 2 diabetes
US7902203B2 (en) 2002-11-01 2011-03-08 Abbott Laboratories, Inc. Anti-infective agents
US7378414B2 (en) 2003-08-25 2008-05-27 Abbott Laboratories Anti-infective agents
US7492956B2 (en) * 2004-08-18 2009-02-17 Cisco Technology, Inc. Video coding using multi-dimensional amplitude coding and 2-D non-zero/zero cluster position coding
CA2578224A1 (en) 2004-08-25 2006-03-09 Essentialis, Inc. Pharmaceutical formulations of potassium atp channel openers and uses thereof
WO2006093801A1 (en) * 2005-02-25 2006-09-08 Abbott Laboratories Thiadiazine derivatives useful as anti-infective agents
EP1777219A1 (en) * 2005-10-20 2007-04-25 Faust Pharmaceuticals 1,2-Substituted naphthalene derivatives with antiglutamatergic properties and uses thereof
AU2006335153B2 (en) 2006-01-05 2012-03-15 Essentialis, Inc. Salts of potassium ATP channel openers and uses thereof
CN100393726C (zh) * 2006-04-20 2008-06-11 山东大学 2,4-二取代杂环并[4,5-e][1,2,4]噻二嗪衍生物制备方法
CN110054647B (zh) * 2019-05-23 2021-06-15 上海勋和医药科技有限公司 托拉塞米磷酸酯类前药、其制备方法及组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3157647A (en) * 1960-10-31 1964-11-17 Olin Mathieson Process for producing nu-alkyl and nu-aralkyl thiadiazine compounds
US3288678A (en) * 1963-09-12 1966-11-29 Ciba Geigy Corp Diuretic compositions
GB1368948A (en) * 1970-11-11 1974-10-02 Manuf Prod Pharma Pyridine derivatives
JPS5854158B2 (ja) * 1975-10-02 1983-12-02 ヒサミツセイヤク カブシキガイシヤ シンキナピリドチアジアジンユウドウタイノセイゾウホウ

Also Published As

Publication number Publication date
ATE174920T1 (de) 1999-01-15
AU673893B2 (en) 1996-11-28
AU5904894A (en) 1994-09-29
DE69415373D1 (de) 1999-02-04
EP0618209B1 (fr) 1998-12-23
JPH072872A (ja) 1995-01-06
ZA942131B (en) 1995-04-05
DE69415373T2 (de) 1999-08-26
FR2703051B1 (fr) 1995-04-28
US5459138A (en) 1995-10-17
NZ260186A (en) 1995-07-26
CA2119853A1 (fr) 1994-09-27
EP0618209A1 (fr) 1994-10-05
CA2119853C (fr) 2002-09-10
JP2513989B2 (ja) 1996-07-10
GR3029406T3 (en) 1999-05-28
DK0618209T3 (da) 1999-08-23
FR2703051A1 (fr) 1994-09-30

Similar Documents

Publication Publication Date Title
ES2128519T3 (es) Nuevas pirido-tiadiazinas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ES2074846T3 (es) Nuevas naftil-etil-ureas y naftil-etil-tioureas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
ES2081187T3 (es) Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ES2123039T3 (es) Nuevas 3-(hidroxi-bencilidenil)-indolin-2-onas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ES2095432T3 (es) Derivados de 2,4-tiazolidin-diona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2097297T3 (es) Isoquinolein-5-il-sulfonamidas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
ES2079719T3 (es) Derivados de amidinofenilalanina, procedimiento para su preparacion, su utilizacion y agentes que los contienen en calidad de anticoagulantes.
ES2103440T3 (es) Nuevas amidas y sulfonamidas naftalenicas, procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ES2111871T3 (es) Nuevos derivados de aminoacidos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2125963T3 (es) Nuevos derivados espiranicos del 3-amino-cromano, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.
AR004476A1 (es) Compuestos biciclicos, su preparacion y su utilizacion en composiciones farmaceuticas
ES2104295T3 (es) Derivados ciclopeptidicos de la angiopeptina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DK0623620T3 (da) 5-HT3-pyrrolopyrazinderivater
ES2123739T3 (es) Nuevos analogos del eburnano, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2095726T3 (es) Piperazinas sustituidas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
ES2095431T3 (es) N-(isoquinolein-5-il)-sulfonil-azacicloalcanos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
FI903701A0 (fi) Reninhaemmande amino-oligohydroxiderivat.
ES2076054T3 (es) Nuevas amino-alquil-cromonas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
ES2103553T3 (es) Nuevos cicloalquil-(b)-indoles, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
MX9300136A (es) Alfa-aril-alfa-hidroxi-beta-imidazolinil-propionamidas, procedimiento para su obtencion y medicamentos que las contienen.
ES2062313T3 (es) 13-bromo- y 13,14-dibromo-ergolinas, a su preparacion y a su utilizacion en medicamentos.
ES2091670T3 (es) Nuevos derivados (ciclohexil)-alquenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ES2071723T3 (es) Bencilseleniobenzoamidas de aminopiridinas y picolilaminas.
PT97255A (pt) Processo para a preparacao de 3-tia-alquil-flavonas e de 3-oxa-alquil flavonas e substituidas e de composicoes farmaceuticas que as contem
ES2123038T3 (es) Nuevos derivados pirrolo-tieno-pirazinicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 618209

Country of ref document: ES